Whalegun
Home

Quang X. Pham, Chairman, CEO and Interim CFO: Cadrenal Therapeutics CVKD Sell · Filed 06/26

Trade details

Type
Insider sale
Amount
$6,381
Shares · price
2,127 sh · $3.00 a share
Held after
115,018 sh
Stock
Cadrenal Therapeutics CVKD
Person
Quang X. PhamChairman, CEO and Interim CFO
Trade date
26/06/25
Filed
26/06/26
Days to filing
1 days

Sold 1.8% of holdings

Share of holding sold
1.8%

Cadrenal Therapeutics trades, last 26 weeks

What else happened in Cadrenal Therapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Quang X. Pham's recent trades

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $27.5K

    Filed 06/26

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $32.5K

    Filed 06/24

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $7,286

    Filed 06/24

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $11.5K

    Filed 06/18

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $1,621

    Filed 06/18

Quang X. Pham, Chairman — sold $6,381 of Cadrenal Therapeutics CVKD · 1.8% of holdings · 10b5-1 plan | Whalegun